CN Patent

CN113061137B — 含氮杂环衍生物或其药学上可接受的盐和用途

Assigned to Guangxi Medical University · Expires 2022-08-02 · 4y expired

What this patent protects

本发明公开了含氮杂环衍生物或其药学上可接受的盐，所述含氮杂环衍生物的通式如式I所示； 本发明还提供了含氮杂环衍生物或其药学上可接受的盐的用途。本发明的含氮杂环衍生物可以有效地选择性地沉默JAK3，并拥有较高的用药安全性。

USPTO Abstract

本发明公开了含氮杂环衍生物或其药学上可接受的盐，所述含氮杂环衍生物的通式如式I所示； 本发明还提供了含氮杂环衍生物或其药学上可接受的盐的用途。本发明的含氮杂环衍生物可以有效地选择性地沉默JAK3，并拥有较高的用药安全性。

Drugs covered by this patent

Patent Metadata

Patent number
CN113061137B
Jurisdiction
CN
Classification
—
Expires
2022-08-02
Drug substance claim
No
Drug product claim
No
Assignee
Guangxi Medical University
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.